RXRX stock

Recursion Pharmaceuticals Inc (RXRX) valuation · rev $74.7M

Recursion Pharmaceuticals Inc (RXRX) rev $74.7M.

Cached valuation scalars
MetricValue
Market cap$1.75B
Revenue$74.7M
P/S23.4
P/B1.7
These valuation metrics as JSON? API free 100/day

RXRX valuation FAQ

What is RXRX's market cap?

Recursion Pharmaceuticals Inc (RXRX) market cap is $1.75B on the latest cached fundamentals snapshot.

What is RXRX's latest revenue?

Latest cached Recursion Pharmaceuticals Inc (RXRX) revenue was $74.7M. Statements: https://lician.com/financials/rxrx

What is RXRX's price-to-sales ratio?

Recursion Pharmaceuticals Inc (RXRX) price-to-sales (P/S) is 23.4, cached market cap $1.75B divided by revenue $74.7M.

What is RXRX's price-to-book ratio?

Recursion Pharmaceuticals Inc (RXRX) price-to-book (P/B) is 1.7 on the latest cached fundamentals snapshot.

How many RXRX valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Recursion Pharmaceuticals Inc (RXRX): Market cap, Revenue, P/S, and P/B.

Where is RXRX valuation listed?

Cached valuation multiples for Recursion Pharmaceuticals Inc (RXRX) are listed at https://lician.com/valuation/rxrx.

Not investment advice. Cached rows, not a live tape.